Company Overview and News

 
Financial Results for the first six months of 2017

2017-08-17 londonstockexchange
Astana, 17 August 2017. JSC KazMunaiGas Exploration Production ("KMG EP" or "the Company") announces its consolidated interim financial results for the first six months ended 30 June 2017.

 
Citic Resources’ interim profit surge on higher oil, commodity prices

2017-07-30 scmp
The company says its coal segment returned to profit in the first-half from a loss in the year-earlier period

 
KMG EP 1Q2017 Finacial Results

2017-04-27 londonstockexchange
Astana, 27 April 2017. JSC KazMunaiGas Exploration Production ("KMG EP" or "the Company") announces its consolidated interim financial results for the first three months ended 31 March 2017.

 
KMG EP 2016 Full Year Financial Results

2017-02-17 londonstockexchange
Astana, 17 February 2016. JSC KazMunaiGas Exploration Production ("KMG EP" or "the Company") announces its consolidated financial statements for the year ended 31 December 2016.

 
KazMunaiGas announces financial results for the first nine months of 2016

2016-11-17 oilvoice
JSC KazMunaiGas Exploration Production announces its consolidated interim financial results for the nine months ended 30 September 2016.

 
Financial Results for the first 9 months of 2016

2016-11-17 londonstockexchange
Astana, 17 November 2016. JSC KazMunaiGas Exploration Production ("KMG EP" or "the Company") announces its consolidated interim financial results for the nine months ended 30 September 2016.

 
Alcoa, Alumina settle dispute, clearing hurdle to Alcoa split

2016-09-02 theage.com.au
Alcoa Inc and Alumina Ltd have settled a dispute and agreed to reshape their joint venture, removing an obstacle to Alcoa's plan to split into two companies and making its Australian partner a more attractive takeover target.

 
Alcoa, Alumina settle dispute, clearing hurdle to Alcoa split

2016-09-02 smh.com.au
Alcoa Inc and Alumina Ltd have settled a dispute and agreed to reshape their joint venture, removing an obstacle to Alcoa's plan to split into two companies and making its Australian partner a more attractive takeover target.

 
KazMunaiGas announces first half 2016 financial results

2016-08-11 oilvoice
JSC KazMunaiGas Exploration Production announces its consolidated interim financial results for the six months ended 30 June 2016.

 
Financial Results for the first six months of 2016

2016-08-11 londonstockexchange
Astana, 11 August 2016. JSC KazMunaiGas Exploration Production ("KMG EP" or "the Company") announces its consolidated interim financial results for the six months ended 30 June 2016.

 
Deals of the day- Mergers and acquisitions

2016-06-22 reuters
June 22 The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Wednesday:

 
ITOCHU Corp. and CITIC Resources sign MoU

2016-06-22 energyglobal
ITOCHU Corp. has announced the signing of a MoU with CITIC Resources Holdings Ltd, for collaboration in oil and gas exploration and production.

 
Energy Markets Daily: PGandE Corporation, BHP Billiton Limited (ADR), SolarCity Corp

2016-06-22 bidnessetc
PG&E Corporation (NYSE:PCG) will shut the last operating nuclear power plant in California, Diablo Canyon, by 2025. The company has asked state officials to replace the generating capacity with renewable power sources. Some analysts are sceptical about the closure saying that it will result in higher energy bills if the company increases its dependence on natural gas for power generation.

 
CITIC Resources to partner with Japan's Itochu on oil, gas projects | Reuters

2016-06-22 reuters
HONG KONG Chinese oilfield operator CITIC Resources Holdings Ltd will join with Japan's Itochu Corp to invest in oil and gas projects, as rising oil prices this year are spurring investments in exploration and production assets.

 
CITIC Resources, ITOCHU Sign MOU to Collaborate on E&P Projects

2016-06-22 rigzone
CITIC Resources Holdings Ltd., a Hong Kong-headquartered natural resources and commodities provider, and Japan's ITOCHU Corp. signed a non-binding memorandum of understanding (MOU) to collaborate on upstream oil and gas exploration and production projects.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...